Biosimilar filgrastim (Zarzio
®
) vs. lenograstim (Myelostim
®
) for peripheral blood stem cell mobilization in adult patients with lymphoma and myeloma: a single center experience
Leuk Lymphoma
.
2016 Feb;57(2):489-492.
doi: 10.3109/10428194.2015.1063147.
Epub 2015 Jul 18.
Authors
Francesco Marchesi
1
,
Michele Vacca
2
,
Svitlana Gumenyuk
1
,
Annino Pandolfi
2
,
Daniela Renzi
1
,
Francesca Palombi
1
,
Francesco Pisani
1
,
Atelda Romano
1
,
Antonio Spadea
1
,
Francesco Ipsevich
2
,
Susanna Santinelli
3
,
Mafalda De Rienzo
3
,
Elena Papa
1
,
Marco Canfora
4
,
Lamberto Laurenzi
5
,
Maria Laura Foddai
3
,
Luca Pierelli
2
,
Andrea Mengarelli
1
Affiliations
1
a Hematology and Stem Cell Transplantation Unit, Regina Elena National Cancer Institute , Rome , Italy.
2
b Immuno-Transfusional Medicine, Leukapheresis and Cellular Therapy Unit, S. Camillo-Forlanini Hospital , Rome , Italy.
3
c Immuno-Transfusional Medicine Unit, Regina Elena National Cancer Institute , Rome , Italy.
4
d Scientific Direction, Regina Elena National Cancer Institute , Rome , Italy.
5
e Intensive Care and Pain Therapy Unit, Regina Elena National Cancer Institute , Rome , Italy.
PMID:
26099572
DOI:
10.3109/10428194.2015.1063147
No abstract available